Seelos Therapeutics’ $5.55 Million Common Stock Offering

Paul Hastings represented Seelos Therapeutics, Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group.Seelos Theraputics Inc. (NASDAQ: SEEL) announced a $5.55 million public offering…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now